2) Di Palma S. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol. 2013;7:S68-76.
3) Lüers JC, Wittekindt C, Streppel M, Guntinas-Lichius O. Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy. Acta Oncol. 2009;48:132-136.
4) Altemani A, Martins MT, Freitas L, Soares F, Araújo NS, Araújo VC. Carcinoma ex pleomorphic adenoma (CXPA): Immunoprofile of the cells involved in carcinomatous progression. Histopathology. 2005;46:635-641.
8) Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, et al. Management of salivary gland malignancy: ASCO guideline. J Clin Oncol. 2021;39:1909-1941.
11) Nakamori K, Ohuchi T, Hasegawa T, Hiratsuka H. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components. Int J Oral Maxillofac Surg. 2009;38:1116-1118.
12) Mantsopoulos K, Bessas Z, Sievert M, Muller SK, Koch M, Agaimy A, et al. Frozen section of parotid gland tumours: The head and neck pathologist as a key member of the surgical team. J Clin Med. 2022;11:1249
https://doi.org/10.3390/jcm11051249.